Amboy Street Ventures
Sophie Reynolds is currently an Associate at Amboy Street Ventures. Prior to this, Sophie held positions at The Janssen Pharmaceutical Companies of Johnson & Johnson as a Senior Global Data Manager and Global Data Manager. Sophie also worked as a Science Editor at Cornell Daily Sun and as a Research Assistant at La Jolla Institute for Immunology, where Sophie co-authored a research publication on the role of Kindlin-3 surface ligands on mononuclear phagocytes. Sophie obtained their Bachelor of Arts in Molecular Biology from Cornell University in May 2020.
This person is not in any teams
Amboy Street Ventures
The world’s first venture capital fund focused on Sexual Health & Women’s Health Technology startups. Amboy Street Ventures invests in the Seed and Series A rounds of Sexual Health & Women’s Health Technology startups that are progressing the industry in America and Europe. Amboy Street Ventures is an active investor and adds value above and beyond capital. Its dedicated Value Enhancement Team supports portfolio companies with marketing & branding, sales & distribution, product development & scientific innovation and public education resources through its position within the Healthy Pleasure Group, an ecosystem dedicated to solving the problems that startups face in the Sexual Health and Women’s Health Tech market.